Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

Company Overview

Walgreens Boots Alliance, Inc. is a global leader in pharmacy, health and wellness retail, and pharmaceutical wholesale and distribution. Formed in December 2014 through the merger of Walgreens, a prominent U.S. drugstore chain, and Alliance Boots, a leading international health and beauty retailer and wholesaler, the company combines a comprehensive network of retail pharmacies, e-commerce platforms and wholesale operations. Its core offerings include prescription drugs, over-the-counter medications, health and beauty products, retail general merchandise and specialty pharmacy services.

The company operates under several banners, most notably Walgreens in the United States and Boots in the United Kingdom and Ireland, serving millions of customers each week. In addition to its consumer-facing retail stores, Walgreens Boots Alliance provides wholesale distribution of pharmaceutical and healthcare products to hospitals, clinics and independent pharmacies through its Alliance Healthcare division. The company continues to invest in digital health initiatives, pharmacy care services and supply chain efficiencies to enhance customer experience and support healthcare providers.

Headquartered in Deerfield, Illinois, Walgreens Boots Alliance maintains a presence across North America, Europe, and selected markets in the Middle East, Asia and Latin America. With a history dating back to Boots’ founding in 1849 in Nottingham, England, the combined entity leverages decades of expertise in retail pharmacy and beauty retailing. The company’s retail formats range from neighborhood drugstores to expanded health and wellness destinations, reflecting its commitment to accessible care and personalized consumer experiences.

Under the leadership of Chief Executive Officer Rosalind “Roz” Brewer and Executive Chairman Stefano Pessina, Walgreens Boots Alliance focuses on integrating its global footprint, optimizing its store portfolio and expanding partnerships in healthcare services. The company aims to drive long-term growth by strengthening its pharmacy-led model, enhancing digital engagement and delivering value to patients, customers and stakeholders worldwide.

Key Stats

• Today's Range: $11.98 to $11.98
• 50-Day Range: $11.52 to $12.20
• 52-Week Range: $10.90 to $12.25
• Volume: N/A
• Average Volume: 14.58 million shs
• Market Capitalization: $10.37 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/26/2025
• Today: 8/02/2026
• Fiscal Year End: 8/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: RETAIL - DRUG STR
• Sub-Industry: Drug Retail
• Current Symbol: NASDAQ:WBA
• CIK: 1618921
• Web: www.walgreensbootsalliance.com
• Phone: (847) 315-3700
• Fax: 847-914-2804
• Employees: 325,000
• Year Founded: 2014

Profitability

• EPS (Trailing Twelve Months): ($7.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.49
• P/E Growth: 1.42
• Net Income: -$8.64 billion
• Net Margins: -4.07%
• Pretax Margin: -3.79%
• Return on Equity: 17.66%
• Return on Assets: 2.22%

Debt

• Debt-to-Equity Ratio: 0.96
• Current Ratio: 0.60
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $147.66 billion
• Price / Sales: 0.07
• Cash Flow: $5.73 per share
• Price / Cash Flow: 2.09
• Book Value: $13.91 per share
• Price / Book: 0.86

Miscellaneous

• Outstanding Shares: 865,560,000
• Free Float: 714,088,000
• Market Cap: $10.37 billion
• Optionable: Optionable
• Beta: 0.80